19.08.2021 • NewsNovavax

Novavax Hires Two Pharma Stalwarts to Push Covid Vaccine

US biotech Novavax, in the final stage of developing its protein-based Covid-19 vaccine, NVX-CoV2373, is adding muscle in human resources before applying to the US Food and Drug Administration, along with other national and international regulators for emergency use authorization in the fourth quarter.

The company has appointed Nasir Egal, a former executive of Sanofi, as new senior vice president of quality assurance, and Jim Kelly, formerly of Supernus Pharmaceuticals, its new chief financial officer and treasurer, to help push the vaccine across the finish line.

Nearly 10 years at Sanofi, Egal’s last position was as head of global quality external affairs. Before joining the French drugmaker, he worked in global and regional quality and compliance at Novartis and Merck & Co. He also served a stint at the FDA as a research scientist.

Kelly last served as CFO of Supernus and prior to that held the job of CFO and treasurer at Vanda Pharmaceuticals, after having financial roles at Biogen and MedImmune. Novavax will count on Kelly’s financial and strategic expertise as it “quickly matures into a global commercial company,” the company’s CEO, Stanley Erck, said.

Author: Dede Williams, Freelance Journalist

US biotech Novavax has signed up two pharma stalwarts to help push its Covid...
US biotech Novavax has signed up two pharma stalwarts to help push its Covid vaccine across the finish line. Nasir Egal, formerly of Sanofi, is new senior vice president of quality assurance, Jim Kelly, formerly of Supernus Pharmaceuticals, chief financial officer and treasurer. (c) Marten Bjork

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.